ATE321778T1 - Maurotoxin, pi1 und hstx1 derivate - Google Patents
Maurotoxin, pi1 und hstx1 derivateInfo
- Publication number
- ATE321778T1 ATE321778T1 AT01980332T AT01980332T ATE321778T1 AT E321778 T1 ATE321778 T1 AT E321778T1 AT 01980332 T AT01980332 T AT 01980332T AT 01980332 T AT01980332 T AT 01980332T AT E321778 T1 ATE321778 T1 AT E321778T1
- Authority
- AT
- Austria
- Prior art keywords
- derivatives
- residue
- maurotoxin
- replaced
- disulfide bridge
- Prior art date
Links
- 101001049892 Scorpio palmatus Potassium channel toxin alpha-KTx 6.2 Proteins 0.000 title abstract 4
- 125000000539 amino acid group Chemical group 0.000 abstract 2
- 108010045489 Calcium-Activated Potassium Channels Proteins 0.000 abstract 1
- 102000005702 Calcium-Activated Potassium Channels Human genes 0.000 abstract 1
- 101001026236 Homo sapiens Intermediate conductance calcium-activated potassium channel protein 4 Proteins 0.000 abstract 1
- 102100037441 Intermediate conductance calcium-activated potassium channel protein 4 Human genes 0.000 abstract 1
- 102000003734 Voltage-Gated Potassium Channels Human genes 0.000 abstract 1
- 108090000013 Voltage-Gated Potassium Channels Proteins 0.000 abstract 1
- 230000004913 activation Effects 0.000 abstract 1
- 230000007170 pathology Effects 0.000 abstract 1
- 238000006467 substitution reaction Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
- C07K14/43513—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from arachnidae
- C07K14/43522—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from arachnidae from scorpions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Insects & Arthropods (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurology (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Neurosurgery (AREA)
- Tropical Medicine & Parasitology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biomedical Technology (AREA)
- Pharmacology & Pharmacy (AREA)
- Hospice & Palliative Care (AREA)
- Immunology (AREA)
- Psychiatry (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0021639A GB0021639D0 (en) | 2000-09-04 | 2000-09-04 | Maurotoxin derivatives |
| GB0024538A GB0024538D0 (en) | 2000-10-06 | 2000-10-06 | Maurotoxin pil and hstx1 derivatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE321778T1 true ATE321778T1 (de) | 2006-04-15 |
Family
ID=26244958
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT01980332T ATE321778T1 (de) | 2000-09-04 | 2001-09-03 | Maurotoxin, pi1 und hstx1 derivate |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US20040039167A1 (de) |
| EP (1) | EP1315747B1 (de) |
| AT (1) | ATE321778T1 (de) |
| AU (1) | AU2002212201A1 (de) |
| DE (1) | DE60118418T2 (de) |
| ES (1) | ES2261491T3 (de) |
| WO (1) | WO2002020596A2 (de) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0414272D0 (en) | 2004-06-25 | 2004-07-28 | Cellpep Sa | OsK1 derivatives |
| PE20081140A1 (es) * | 2006-10-25 | 2008-09-22 | Amgen Inc | Agentes terapeuticos a base de peptidos derivados de toxinas |
| JP5591691B2 (ja) * | 2007-05-22 | 2014-09-17 | アムジエン・インコーポレーテツド | 生物活性を有する融合タンパク質を作製するための組成物及び方法 |
| DE202013104200U1 (de) | 2013-09-13 | 2013-10-10 | Flühs Drehtechnik GmbH | Einhandhebelkartusche |
| US9708377B2 (en) | 2013-10-28 | 2017-07-18 | Monash University | Scorpion toxin analogue and method for treating autoimmune diseases |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2121137A1 (en) * | 1991-10-12 | 1993-04-29 | Bob B. Buchanan | Use of thiol redox proteins for reducing disulfide bonds |
| US6187579B1 (en) * | 1993-10-28 | 2001-02-13 | Carlsberg A/S | Customized proteases |
| CA2253937A1 (en) * | 1996-05-10 | 1997-11-20 | Phylomed Corporation | Methods for oxidizing disulfide bonds using ozone |
| GB9627115D0 (en) * | 1996-12-31 | 1997-02-19 | Centre Nat Rech Scient | Alpha-amino-butyrate derivatives of venoms |
-
2001
- 2001-09-03 US US10/363,622 patent/US20040039167A1/en not_active Abandoned
- 2001-09-03 WO PCT/EP2001/010173 patent/WO2002020596A2/en not_active Ceased
- 2001-09-03 AT AT01980332T patent/ATE321778T1/de not_active IP Right Cessation
- 2001-09-03 ES ES01980332T patent/ES2261491T3/es not_active Expired - Lifetime
- 2001-09-03 AU AU2002212201A patent/AU2002212201A1/en not_active Abandoned
- 2001-09-03 EP EP01980332A patent/EP1315747B1/de not_active Expired - Lifetime
- 2001-09-03 DE DE60118418T patent/DE60118418T2/de not_active Expired - Lifetime
-
2008
- 2008-01-22 US US12/009,675 patent/US7829666B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| US7829666B2 (en) | 2010-11-09 |
| AU2002212201A1 (en) | 2002-03-22 |
| DE60118418D1 (de) | 2006-05-18 |
| EP1315747B1 (de) | 2006-03-29 |
| ES2261491T3 (es) | 2006-11-16 |
| WO2002020596A3 (en) | 2002-08-01 |
| US20040039167A1 (en) | 2004-02-26 |
| EP1315747A2 (de) | 2003-06-04 |
| WO2002020596A2 (en) | 2002-03-14 |
| DE60118418T2 (de) | 2007-01-11 |
| US20090062198A1 (en) | 2009-03-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1877435T3 (da) | Glucagon-lignende peptid 2 (GLP-2)-analoger | |
| CY1113850T1 (el) | Νεα παραγωγα ινσουλινης | |
| BRPI0414062A (pt) | uso de ciclosporinas midificadas para o tratamento de distúrbios por hcv | |
| ATE417595T1 (de) | Keratin-bindende polypeptide | |
| MX2009004701A (es) | Analogos selectivos del peptido 2 similar al glucagon. | |
| BR0209312A (pt) | Composição alimentìcia de isolado de proteìna de canola | |
| BR122016022033B8 (pt) | conjugados de polipeptídeo isolado apresentando atividade pró-coagulante de fator viii, seu uso e composição farmacêutica | |
| CY1108843T1 (el) | 3,11β cis διϋδροτετραβεναζινη για την θεραπεια της σχιζοφρενιας και αλλων ψυχωσεων | |
| BR0213207A (pt) | remodelagem e glicoconjugação de peptìdeos | |
| CY1115084T1 (el) | Καθηλωμενα επι εκμαγειου πεπτιδομιμητικα βητα-φουρκετας με δραση αναστολης πρωτεασης | |
| CY1105452T1 (el) | Παραγωγα της κυκλοσπορινης και μεθοδος παρασκευης των εν λογω παραγωγων | |
| EP1487854A4 (de) | Neue isoformen des gefässendothel-zellwachstumshemmers | |
| DE60118418D1 (de) | Maurotoxin, pi1 und hstx1 derivate | |
| AR038900A1 (es) | Moleculas similares al interferon beta para el tratamiento del derrame cerebral | |
| BRPI0411820A (pt) | composição farmacêutica | |
| GEP20084464B (en) | Mutated neublastin | |
| DE60018937D1 (de) | Somatostatin analoge und deren verwendung zur behandlung von krebs | |
| CY1111301T1 (el) | Πολυπεπτιδια που προερχονται απο προδρομο πεπτιδιο αμυλοειδους (αρρ) και οι χρησεις αυτων | |
| EP2182061A4 (de) | Neuer tumormarker für pankreaskarzinom | |
| CY1113827T1 (el) | Cop 1 για την αγωγη των φλεγμονωδων παθησεων του εντερου | |
| CY1113442T1 (el) | Πεπτιδια που δεσμευονται στον υποδοχεα ερυθροποιητινης | |
| ECSP003457A (es) | Derivados de proteina c | |
| ATE492637T1 (de) | An die lck-sh3 und hck-sh3 domäne bindende peptide |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |